Hyperglycemia in acute heart failure: An opportunity to intervene?

Current Heart Failure Reports

Volumn 11, Issue 3, 2014, Pages 241-245

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Gensini, Gian Franco ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acute heart failure; Diabetes mellitus; Hyperglycemia; Mortality

Indexed keywords

GLUCOSE;

ACUTE HEART FAILURE; ARTICLE; DIABETES MELLITUS; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; PROGNOSIS; ACUTE DISEASE; COMPLICATION; HEALTH; HEART FAILURE; METABOLISM; MORBIDITY; TRENDS;

ACUTE DISEASE; GLOBAL HEALTH; HEART FAILURE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MORBIDITY; PROGNOSIS;

EID: 84906056260     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-014-0205-9     Document Type: Article

References (48)

1. Allen LA, Hernandez AF, O'Connor CM, Felker GM. End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol. 2009;53(24):2248-58.
2. Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, et al. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims. A scientific statement from the American Heart Association. Circulation. 2010;122(19):1975-96.
3. Loomba RS, Arora R. Hyperglycemia and acute coronary syndrome: a systematic review of hyperglycemia's impact on ACS. Am J Ther. 2010;17(2):e48-51.
4. Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med (Hagerstown). 2010;11(1):7-13.
5. Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation. 2005;111(6):754-60. (Pubitemid 40250636)
6. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005;26(13):1255-61. (Pubitemid 41435454)
7. Goyal A,Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27(11):1289-97. (Pubitemid 43998101)
8. Deedwania P, Kosiborod M, Barrett E, American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism, et al.Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;117(12):1610-9. (Pubitemid 351440650)
9. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117(8): 1018-27.
10. Kosiborod M, Rathore SS, Inzucchi SE. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111(23):3078-86. (Pubitemid 40847785)
11. Deane AM, Horowitz M. Dysglycaemia in the critically ill-significance and management. Diabetes Obes Metab. 2013;15(9):792-801.
12. Van Herpe T,Mesotten D. Blood glucose measurements in critically ill patients. J Diabetes Sci Technol. 2012;6(1):22-8.
13. Kaukonen KM, Bailey M, Pilcher D, Orford N, Finfer S, Bellomo R. Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study. Crit Care. 2013;17(5):R215.
14. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007;114(2): 176-82. (Pubitemid 44802898)
15. Pres D, Gasior M, Strojek K, Gierlotka M, Hawranek M, Lekston A, et al. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention. Kardiol Pol. 2010;68(7):743-51.
16. Vis MM, Sjauw KD, van der Schaaf RJ, Baan Jr J, Koch KT, DeVries JH, et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patientswithout a prior diagnosis of diabetes. Am Heart J. 2007;154(6):1184-90. (Pubitemid 350116035)
17. Nishio K, Shigemitsu M, Kusuyama T, et al. Insulin resistance in nondiabetic patients with acute myocardial infarction. Cardiovasc Revasc Med. 2006;7(2):54-60. (Pubitemid 43816365)
18. Wallander M, Bartnik M, Efendic S. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study.Diabetologia. 2005;48(11): 2229-35. (Pubitemid 41618911)
19. Lazzeri C, Sori A, Chiostri M, Picariello C, Gensini GF, Valente S. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol. 2009;26(10):856-62.
20. Caccamo G, Bonura F, Bonura F, Vitale G, Novo G, Evola S, et al. Insulin resistance and acute coronary syndrome. Atherosclerosis. 2010;211(2):672-5.
21. Kosiborod M, Inzucchi SE, Spertus JA, et al. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation. 2009;119(14):1899-907.
22. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001-9.
23. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112(25):3958-68. (Pubitemid 43739494)
24. Pang PS, Komajda M, Gheorghiade M. The current and future management of acute heart failure syndromes. Eur Heart J. 2010;31(7):784-93.
25. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G,McMurray JJ, Ponikowski P, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388-442.
26. Fonarow GC, Adams Jr KF, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-80. (Pubitemid 40171239)
27. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Køber L, et al. Influence of diabetes and diabetesgender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol. 2004;43:771-7. (Pubitemid 38296474)
28. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G. A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J. 2000;21(9):763-9.
29. Permanyer Miralda G, Soriano N, Brotons C, Moral I, Pinar J, Cascant P, et al. Baseline characteristics and determinants of outcome in a patient population admitted for heart failure to a general hospital. Rev Esp Cardiol. 2002;55:571-8. (Pubitemid 34752761)
30. Filippatos G, Farmakis D, Bistola V, Karavidas A, Mebazaa A, Maggioni AP, et al. Temporal trends in epidemiology, clinical presentation and management of acute heart failure: results from the Greek cohorts of the Acute Heart Failure Global Registry of Standard Treatment and the European Society of Cardiology- Heart Failure pilot survey. Eur Heart J Acute Cardiovasc Care 2014;1-7.
31. McDermott MM, Feinglass J, Lee P,Mehta S, Schmitt B, Lefevre F, et al. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J. 1997;134:728-36. (Pubitemid 27465069)
32. Philbin EF, McCullough PA, Dec GW, DiSalvo TG. Length of stay and procedure utilization are the major determinants of hospital charges for heart failure. Clin Cardiol. 2001;24(1): 56-62. (Pubitemid 32045669)
33. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43(1):61-7. (Pubitemid 38045917)
34. Spinar J, Parenica J, Vitovec J, Widimsky P, Linhart A, Fedorco M, et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care. 2011;15(6):R291. doi:10.1186/cc10584.
35. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27:2725-36. (Pubitemid 44729876)
36. Siirilä-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP, et al. Characteristics, outcomes, and predictors of 1- year mortality in patients hospitalized for acute heart failure. Eur Heart J. 2006;27:3011-7. (Pubitemid 44950446)
37. Follath F, Delgado JF,Mebazaa A, Parissis JT, Villas Boas F, Smith H. Classifying patients with acute heart failure presentation, treatment and outcome. A nine country survey of acute heart failure management (ALARM-HF). Eur J Heart Fail. 2008;7(suppl):64.
38. • Shah R, Gayat E, Januzzi Jr JL, Sato N, Cohen-Solal A, Disomma S, et al. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol. 2014;63(8):778-85. An interesting study addressing the relation between BMI and hyperglycemia in AHF patients.
39. • Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, et al. Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol. 2013;61(8):820-9. An interesting investigation addressing in a large cohort of patients the relation between admission glycemia and prognosis.
40. Lazzeri C, Valente S, Attanà P, Chiostri M, Picariello C, Gensini GF. Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes. Intern Emerg Med. 2012;7(6):497-503.
41. Gebreegziabher Y, McCullogh PA, Bubb C, Loney-Hutchison L, Makaryus JN,AnandN, et al. Admission hyperglycemia and lenght of hospital sty in patients with diabetes and heart failure: a prospective cohort study. Congest Heart Fail. 2008;14:117-20.
42. Suskin N, McKelvie RS, Burns RJ, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J. 2000;21:1368-75. (Pubitemid 30599132)
43. Newton JD, Squire IB. Plasma glucose and haemoglobin in the assessment of prognosis following first hospitalisation for heart failure [published online ahead of print April 18, 2006]. Heart. doi:10.1136/hrt.2005.080895.
44. Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med. 2006;166:1613-9. (Pubitemid 44232369)
45. .• Berry C, Brett M, Stevenson K,McMurray JJ, Norrie J. Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart. 2008;94(3):296-304. Abnormal glucose tolerance (and not simply hyperglycemia) is investigated in acute heart failure patients. (Pubitemid 351303420)
46. Shook MS, Zafarullah H, Nelson MD, Bhattacharya SK, Davis RC, Newman KP, et al. Normoglycemia in nondiabetic African Americans hospitalized with heart failure. Am J Med Sci. 2009;338(4):255-8.
47. Novack V, Pencina M, Zahger D, Fuchs L, Nevzorov R, Jotkowitz A, et al. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS One. 2010;5(8):e12184. doi:10.1371/journal.pone.0012184.
48. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de BoerMJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force onDiabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28:88-136. (Pubitemid 46137814)